IPO registrations (S-1, F-1) · Registrants

Vericel Corp

SEC CIK
887359 · filings on EDGAR ↗
Name on the registration
AASTROM BIOSCIENCES INC
Former names
AASTROM BIOSCIENCES INC (1996–2014)
Registration
Form S-1, first filed 1996-11-01, last 2014-09-08; 6 initial registrations, 19 amendments
Outcome
Final prospectus filed 1997-02-04; declared effective 2008-11-24
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
MI
Business address
25 BLUE SKY DRIVE, Burlington, MA 01803
EIN
94-3096597
Ticker
VCEL (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Vericel Corp on the corporate pages

Filings 43

FiledFormWhat it isName as filedEDGAR
1996-11-01S-1S-1 (registration)AASTROM BIOSCIENCES INC0000950130-96-004174 ↗
1996-11-18S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001017062-96-000579 ↗
1996-12-20S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0000898430-96-005817 ↗
1997-01-07S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001017062-97-000006 ↗
1997-01-28S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001017062-97-000095 ↗
1997-01-29S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001017062-97-000105 ↗
1997-01-30S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001017062-97-000108 ↗
1997-02-04424B1424B1 (final prospectus)AASTROM BIOSCIENCES INC0001017062-97-000128 ↗
1997-10-08S-1S-1 (registration)AASTROM BIOSCIENCES INC0000950130-97-004416 ↗
1997-11-05S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001012870-97-002143 ↗
1997-11-20S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001012870-97-002330 ↗
1997-11-21S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001012870-97-002340 ↗
1997-11-25S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001012870-97-002356 ↗
1997-11-26424B4424B4 (final prospectus)AASTROM BIOSCIENCES INC0001012870-97-002367 ↗
2008-11-24EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-08-003502 ↗
2008-11-26EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-08-003515 ↗
2009-03-19EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-09-000664 ↗
2009-06-17S-1S-1 (registration)AASTROM BIOSCIENCES INC0000950123-09-014737 ↗
2009-06-29EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-09-001801 ↗
2010-04-12EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-10-001009 ↗
2010-11-29EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-10-003395 ↗
2011-07-18EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-11-002163 ↗
2012-03-30EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-12-000900 ↗
2013-04-29S-1S-1 (registration)AASTROM BIOSCIENCES INC0001104659-13-033806 ↗
2013-05-13S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-040568 ↗
2013-07-25S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-056497 ↗
2013-08-08S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-061769 ↗
2013-08-12S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-062823 ↗
2013-08-13S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-062903 ↗
2013-08-13S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-13-062989 ↗
2013-08-13EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-13-002393 ↗
2014-02-10S-1S-1 (registration)AASTROM BIOSCIENCES INC0001104659-14-008107 ↗
2014-03-26S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001104659-14-022982 ↗
2014-04-03EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-14-000868 ↗
2014-08-06S-1S-1 (registration)AASTROM BIOSCIENCES INC0001104659-14-057562 ↗
2014-09-02S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001047469-14-007286 ↗
2014-09-08S-1/AS-1/A (amendment)AASTROM BIOSCIENCES INC0001047469-14-007454 ↗
2014-09-10EFFECTEFFECT (declared effective)AASTROM BIOSCIENCES INC9999999995-14-002718 ↗
2014-09-11424B4424B4 (final prospectus)AASTROM BIOSCIENCES INC0001047469-14-007564 ↗
2015-07-15EFFECTEFFECT (declared effective)Vericel Corp9999999995-15-001917 ↗
2015-07-15EFFECTEFFECT (declared effective)Vericel Corp9999999995-15-001918 ↗
2015-07-15EFFECTEFFECT (declared effective)Vericel Corp9999999995-15-001930 ↗
2015-07-15EFFECTEFFECT (declared effective)Vericel Corp9999999995-15-001931 ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ZERBE ROBERT L MDDirector432006–2026
SIMS NELSON MDirector162006–2015
ARMSTRONG R DOUGLAS PHDDirector; OfficerCEO and Chairman of the Board; Chairman and CEO32006
Brennan Gerald JROfficerVP Admin. and Finance, CFO; VP Admin. & Finance, CFO72006–2007
Hock Janet MaryOfficerVP Global Research & CSO12006
SUDOVAR STEPHENDirector62006–2008
DUNBAR GEORGE W JRDirector; Director,Officer; OfficerCEO and President; CEO, President and Director; President & CEO102006–2010
BARD ROBERTOfficerVP Reg-Clinic Affairs &, QS.12006
HAMPSON BRIANOfficerVP Product Development12006
Elmar BurchardtOfficerVP Medical Affiars12006
Bartel RonndaOfficerChief Scientific Officer; VP Research & Development82006–2012
Rubino Alan LDirector312006–2026
WYANT SUSANDirector22006–2007
MAYLEBEN TIMOTHY MDirector; Director,OfficerCEO and President; CEO & President; CEO, President and Director; CEO, President, CFO & Director; President and CEO182006–2012
Urschel Harold C JrDirector82009–2012
Durbin ScottOfficerCFO; CFO and Treasurer; Chief Financial Officer82010–2012
CRESSWELL RONALD MDirector82010–2013
Watling SharonOfficerVice President; VP Clinical Development42011–2012
Gibson BrianOfficerVice President32011–2012
Orlando DanielOfficerChief Operating Officer; Interim CEO142012–2020
Colangelo DominickDirector,OfficerPresident and CEO612013–2026
DART KENNETH BRYANTenPercentOwner22013–2014
Eastern Capital LTDTenPercentOwner22013–2014
Portfolio Services Ltd.TenPercentOwner22013–2014
Elliston Michael W.OfficerController22013–2014
Hagen HeidiDirector212013–2026
MICHEL GERARD JOfficerCFO and VP, Corp. Development; CFO & VP , Corp. Development272014–2020
BLUTT MITCHELL J MDOther; TenPercentOwner42014–2016
Consonance Capital Management LPOther; TenPercentOwner42014–2016
Consonance Capman GP, LLCOther; TenPercentOwner42014–2016
GILMAN STEVEN CDirector242015–2024
MCLAUGHLIN KEVIN FDirector242015–2026
Wotton Paul KDirector232015–2026
Halpin MichaelOfficerChief Operating Officer402019–2026
Flynn Sean C.OfficerChief Legal Officer; SVP, General Counsel; VP, General Counsel282020–2026
Hopper Jonathan MarkOfficerChief Medical Officer372020–2026
Pennell SandraOfficerVP and Corporate Controller12020
Mara Joseph Anthony JrOfficerChief Financial Officer232021–2026
WRIGHT LISADirector112021–2026
SIEGAL JONATHANOfficerPrincipal Accounting Officer262022–2026
Mahoney KarenOfficerChief Human Resources Officer42025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2012-03-23AASTROM BIOSCIENCES INCBiotechnology$40,001,000$40,001,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.